Vecuronium
وکورونیوم
🦴 Musculo-Skeletal SystemNon-depolarising neuromuscular blocker
Market / country: 🇺🇸 USA
Vecuronium (US)
🧮 Dose calculator
Tracheal intubation and neuromuscular blockade · Regimen source: FDA Vecuronium · Dosage and Administration
- • Maintenance 0.01–0.015 mg/kg, first at 25–40 min then about every 12–15 min. Potentiated by inhaled anaesthetics. Infants 7 weeks–1 y are more sensitive and recover more slowly. FDA Vecuronium · Dosage and AdministrationFDA Vecuronium · Pediatric Use
- • Only by personnel trained in anaesthesia, with airway, ventilation and resuscitation equipment at hand. FDA Vecuronium · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to vecuronium. FDA Vecuronium · Contraindications
Warnings
- • Only with ventilatory support available; does not cause unconsciousness (adequate anaesthesia required); anaphylaxis; residual paralysis — monitor with a peripheral nerve stimulator. FDA Vecuronium · Warnings
Formulations
- 10 mg vial — powder for injection 🇺🇸 USA FDA Vecuronium · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Vecuronium · Pregnancy: Teratogenic Effects; Pregnancy Category C:
“Animal reproduction studies have not been conducted with vecuronium.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Vecuronium · Nursing Mothers:
“Because many drugs are excreted in human milk, caution should be exercised when vecuronium is administered to a nursing woman.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Vecuronium · Pediatric Use:
“The safety and effectiveness of vecuronium in pediatric patients less than 7 weeks of age have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Vecuronium · Geriatric Use:
“Dose selections for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA079001
- DailyMed (FDA label)FDA Vecuronium
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDM03AC03
- Darooyab (Iran)Vecuronium-Bromide
🇮🇷 Registered in Iran Darooyab · G-2814/Vecuronium-Bromide
Dosage forms with Iranian generic codes, per Darooyab.
- 01705 · VECURONIUM BROMIDE 10MG VIAL · ویال وکورونیوم بروماید ۱۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Vecuronium · How SuppliedFDA Vecuronium · Dosage and AdministrationFDA Vecuronium · Pediatric UseFDA Vecuronium · ContraindicationsFDA Vecuronium · WarningsFDA Vecuronium · Pregnancy: Teratogenic Effects; Pregnancy Category C:FDA Vecuronium · Nursing Mothers:FDA Vecuronium · Pediatric Use:FDA Vecuronium · Geriatric Use:FDA Vecuronium · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2814/Vecuronium-Bromide
- Clinical review⚠ Unverified